Cargando…
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
Therapeutic treatment of bleeds with FVIII can lead to an antibody response that effectively inhibits its function. Herein, we review the factors that contribute to this immunogenicity and possible ways to overcome it.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978909/ https://www.ncbi.nlm.nih.gov/pubmed/32010137 http://dx.doi.org/10.3389/fimmu.2019.03078 |